Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co

Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co

Submitted by admin on November 25, 2019 - 9:46pm
Source: 
Endpoints
News Tags: 
Mark Timney
Purdue Pharma
Novartis
Medicines Company
M&A
Headline: 
Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co
snippet: 

Mark Timney, the ex-Purdue Pharma CEO named in dozens of lawsuits against the OxyContin maker, stands to earn over $85 million in Novartis’s $9.7 billion buyout of the Medicines Company.

Do Not Allow Advertisers to Use My Personal information